#Biotherapeutics

2025-02-11

The video 🎥 of the #BeilsteinTalk “Inspirations for the delivery of biotherapeutic drugs across biological barriers" with Stefaan De Smedt, Ghent University, is NOW available 🔓 in the video portal @TIB_AVPortal of the @tibhannover:
🔗 av.tib.eu/media/69825

#Nanomedicine #NucleicAcid #Biotherapeutics #DrugDelivery #BeilsteinTalks

2025-01-22

Starting TOMORROW 📅 Jan. 23, 2025 🕒 3–4 pm CET:
Online #BeilsteinTalk “Inspirations for the delivery of biotherapeutic drugs across biological barriers" with Stefaan De Smedt, Ghent University.

FREE registration is still possible 🔗 beilstein-institut.de/en/talks

#Nanomedicine #NucleicAcid #Biotherapeutics #DrugDelivery #BeilsteinTalks

2025-01-16

Coming up next week 📅 Jan. 23, 2025 🕒 3–4 pm CET:

Online #BeilsteinTalk “Inspirations for the delivery of biotherapeutic drugs across biological barriers" with Stefaan De Smedt, Ghent University.

Register for FREE! 🔗 beilstein-institut.de/en/talks

#Nanomedicine #NucleicAcid #Biotherapeutics #DrugDelivery #BeilsteinTalks

2025-01-09

Save the date: 📅 Jan. 23, 2025 🕒 3–4 pm CET

Online #BeilsteinTalk “Inspirations for the delivery of biotherapeutic drugs across biological barriers" with Stefaan De Smedt, Ghent University.

Register for FREE! 🔗 beilstein-institut.de/en/talks

#Nanomedicine #NucleicAcid #Biotherapeutics #DrugDelivery #BeilsteinTalks

GEMMA Biotherapeutics Secures $34 Million Seed Funding

GEMMA Biotherapeutics is a new therapeutics company established by Dr. Jim Wilson, a gene therapy specialist, and has closed its seed funding at $34 million. This investment will support the company’s clinical-stage gene therapy programs and growth of operations.

Visit: nextdigitalhealth.com/funding-

nemo™ 🇺🇦nemo@mas.to
2024-01-13

"A Robust Purity #Method for #Biotherapeutics Using New Peak #Detection in an LC–MS-Based Multi-Attribute Method"

pubs.acs.org/doi/abs/10.1021/j

2023-04-04

After unpacking, getting ready for Day 2 of the Symposium, to bring #biofabrication and #orthoregeneration into tomorrow's panel discussion on Technologies for Organ Manufacturing! @on_found @ISBioFab
---
RT @MayoRegMed
.@MayoClinic Symposium on Regenerative Medicine & Surgery 2023 kicks off today with a look at Mayo's pivot toward #biomanufacturing new #biotherapeutics for rare and complex conditions. #MCRegenMed23
mayocl.in/40…
twitter.com/MayoRegMed/status/

2022-11-10

Client Info

Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst